Kiai Parsa purchased $9K of MED (indirect holdings)
Kiai Parsa purchased 661 indirectly-held shares of MEDIFAST INC (MED) at $13.03 on 2026-11-04.
How this was made
The 30-second read
Why it matters
The filing provides a fresh, primary source of insider activity but the transaction size is small, limiting market impact.
Market read
A modest insider buy that is unlikely to affect MED's price materially.
What to watch
Potential upcoming corporate actions or strategic moves not disclosed could make the purchase more meaningful.
Background
SEC Form 4 filing discloses an insider purchase by a director of Medifast, Inc.
Ticker impact
Director Kiai Parsa bought 661 shares of MED at $13.03, increasing his holdings to 21,089 shares.
minor upward pressure as a small signal of confidence
Form 4 filing shows a $8.6k purchase by a director; the amount is trivial relative to market cap, so any price effect will be limited.
Market effects
none
none
none
Counterpoint
The purchase may be routine portfolio rebalancing rather than a confidence signal.
Key entities
- companyMedifast Inc.
US‑listed health and nutrition company (ticker MED).
- personKiai Parsa
Director of Medifast who made the purchase.



